Literature DB >> 21235236

Mutational analysis of catecholamine binding in tyrosine hydroxylase.

Gabrielle D Briggs1, Sarah L Gordon, Phillip W Dickson.   

Abstract

Tyrosine hydroxylase (TH) performs the first and rate-limiting step in the synthesis of catecholamines, which feed back to regulate the enzyme by irreversibly binding to a high-affinity site and inhibiting TH activity. Phosphorylation of Ser40 relieves this inhibition by allowing dissociation of catecholamine. We have recently documented the existence of a low-affinity catecholamine binding which is dissociable, is not abolished by phosphorylation, and inhibits TH by competing with the essential cofactor, tetrahydrobiopterin. Here, we have substituted a number of active site residues to determine the structural nature of the low- and high-affinity sites. E332D and Y371F increased the IC(50) of dopamine for the low-affinity site 10-fold and 7 0-fold, respectively, in phosphorylated TH, indicating dramatic reductions in affinity. Only 2-4-fold increases in IC(50) were measured in the nonphosphorylated forms of E332D and Y371F and also in L294A and F300Y. This suggests that while the magnitude of low-affinity site inhibition in wild-type TH remains the same upon TH phosphorylation as previously shown, the active site structure changes to place greater importance on E332 and Y371. Changes to high affinity binding were also measured, including a loss of competition with tetrahydrobiopterin for E332D, A297L, and Y371F and a decreased ability to inhibit catalysis (V(max)) for A297L and Y371F. The common roles of E332 and Y371 indicate that the low- and high-affinity catecholamine binding sites are colocalized in the active site, but due to simultaneous binding, may exist in separate monomers of the TH tetramer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235236     DOI: 10.1021/bi101455b

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Common somatic alterations identified in maffucci syndrome by molecular karyotyping.

Authors:  Mustapha Amyere; Anne Dompmartin; Vinciane Wouters; Odile Enjolras; Ilkka Kaitila; Pierre-Louis Docquier; Catherine Godfraind; John Butler Mulliken; Laurence Myriam Boon; Miikka Vikkula
Journal:  Mol Syndromol       Date:  2014-08-26

Review 2.  Complex molecular regulation of tyrosine hydroxylase.

Authors:  Izel Tekin; Robert Roskoski; Nurgul Carkaci-Salli; Kent E Vrana
Journal:  J Neural Transm (Vienna)       Date:  2014-05-28       Impact factor: 3.575

3.  The sustained phase of tyrosine hydroxylase activation in vivo.

Authors:  Lin Kooi Ong; Luba Sominsky; Phillip W Dickson; Deborah M Hodgson; Peter R Dunkley
Journal:  Neurochem Res       Date:  2012-06-09       Impact factor: 3.996

4.  De novo production of the key branch point benzylisoquinoline alkaloid reticuline in yeast.

Authors:  Isis J Trenchard; Michael S Siddiqui; Kate Thodey; Christina D Smolke
Journal:  Metab Eng       Date:  2015-07-10       Impact factor: 9.783

5.  Changes in Tyrosine Hydroxylase Activity and Dopamine Synthesis in the Nigrostriatal System of Mice in an Acute Model of Parkinson's Disease as a Manifestation of Neurodegeneration and Neuroplasticity.

Authors:  Anna Kolacheva; Leyla Alekperova; Ekaterina Pavlova; Alyona Bannikova; Michael V Ugrumov
Journal:  Brain Sci       Date:  2022-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.